Fast Healthcare Interoperability Resources (FHIR®) Representation of Medication Data Derived from German Procedure Classification Codes (OPS) Using Identification of Medicinal Products (IDMP) Compliant Terminology.

FHIR Health Information Interoperability Identification of Medicinal Products (IDMP) Medication

Journal

Studies in health technology and informatics
ISSN: 1879-8365
Titre abrégé: Stud Health Technol Inform
Pays: Netherlands
ID NLM: 9214582

Informations de publication

Date de publication:
24 May 2021
Historique:
entrez: 27 5 2021
pubmed: 28 5 2021
medline: 1 6 2021
Statut: ppublish

Résumé

Electronic documentation of medication data is one of the biggest challenges associated with digital clinical documentation. Despite its importance, it has not been consistently implemented in German university hospitals. In this paper we describe the approach of the German Medical Informatics Initiative (MII) towards the modelling of a medication core dataset using FHIR® profiles and standard-compliant terminologies. The FHIR profiles for Medication and MedicationStatement were adapted to the core dataset of the MIl. The terminologies to be used were selected based on the criteria of the ISO-standard for the Identification of Medicinal Products (IDMP). For a first use case with a minimal medication dataset, the entries in the medication chapter of the German Procedure Classification (OPS codes) were analyzed and mapped to IDMP-compliant medication terminology. OPS data are available at all German hospitals as they are mandatory for reimbursement purposes. Reimbursement-relevant encounter data containing OPS medication procedures were used to create a FHIR representation based on the FHIR profiles MedicationStatement and Medication. This minimal solution includes - besides the details on patient and start-/end-dates - the active ingredients identified by the IDMP-compliant codes and - if specified in the OPS code - the route of administration and the range of the amount of substance administered to the patient, using the appropriate unit of measurement code. With FHIR, the medication data can be represented in the data integration centers of the MII to provide a standardized format for data analysis across the MII sites.

Identifiants

pubmed: 34042899
pii: SHTI210074
doi: 10.3233/SHTI210074
doi:

Types de publication

Journal Article

Langues

eng

Pagination

231-236

Auteurs

Julian Sass (J)

Berlin Institute of Health (BIH), Germany.

Susanne Zabka (S)

Institute for Medical Biometry and Medical Informatics, University of Freiburg, Freiburg, Germany.

Andrea Essenwanger (A)

Berlin Institute of Health (BIH), Germany.

Josef Schepers (J)

Berlin Institute of Health (BIH), Germany.

Martin Boeker (M)

Institute for Medical Biometry and Medical Informatics, University of Freiburg, Freiburg, Germany.

Sylvia Thun (S)

Berlin Institute of Health (BIH), Germany.
Charité - Universitätsmedizin Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH